CHMP recommends two new drugs for approval and rejects one

Japanese firm Kyowa Kirin's Parkinson's disease treatment was given a negative opinion at the council's meeting in July. Two other drugs were recommended for approval.
Photo: Rob Acket/EMA
Photo: Rob Acket/EMA

The CHMP (Committee for Medicinal Products for Human use) did not have many drugs to consider in July.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading